8-KEarnings & ResultsExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (May 15, 2006)

Filed May 15, 2006For Securities:DXCM

Summary

This Form 8-K filing by DexCom, Inc. (DXCM) from May 15, 2006, primarily serves to report its financial results and other pertinent information for the quarter ended March 31, 2006. The key takeaway for investors is the disclosure of the company's operational and financial performance during this period. This filing is important as it provides a snapshot of DexCom's financial condition at that time, allowing investors to assess its progress and potential. The filing itself does not contain detailed financial tables but rather references an attached press release (Exhibit 99.01) which contains the actual financial results. Investors should refer to this press release for specific figures related to revenue, expenses, profitability, and any other significant financial metrics reported for the first quarter of 2006. The information is furnished and not considered 'filed' for certain regulatory purposes, a common distinction in SEC filings.

Key Highlights

  • 1DexCom, Inc. (DXCM) filed a Form 8-K on May 15, 2006.
  • 2The filing reports financial results for the quarter ended March 31, 2006.
  • 3A press release detailing these financial results is furnished as Exhibit 99.01.
  • 4The press release is incorporated by reference into the 8-K filing.
  • 5The disclosed information pertains to the company's operations and financial condition.
  • 6The filing's purpose is to provide timely updates on material events.
  • 7The Chief Financial Officer, Steven J. Kemper, signed the report.

Frequently Asked Questions

The primary purpose of this Form 8-K filing is to report DexCom, Inc.'s financial results and other material information for the quarter that ended on March 31, 2006. It serves as an official disclosure to investors about the company's performance during that period.

The specific financial results are detailed in the press release dated May 15, 2006, which is included as Exhibit 99.01 to this Form 8-K filing. Investors should review this exhibit for detailed financial figures.

No, the information furnished in this report, including the press release, is specifically stated as being furnished pursuant to Item 2.02 of Form 8-K. This means it is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor is it automatically incorporated by reference into other filings.

While this specific 8-K filing focuses on financial results, DexCom, Inc. is generally known for developing and commercializing continuous glucose monitoring (CGM) systems for diabetes management. This filing provides an update on their financial performance related to this business.